FDA Inspection 845578 — Biomat USA, Inc

Biomat USA, Inc — FEI 1640366

The FDA completed an inspection of Biomat USA, Inc on August 23, 2013 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Denver, CO (United States)